Search research articles
Contact Us
Filters
Showing results (101-110 of 263) with videos related to
Page
of 27
Sort By:
Frontiers in Immunology
|
August 10, 2023
Molecular signature associated with cladribine treatment in patients with multiple sclerosis
Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Genome Biology and Evolution
|
April 1, 2014
Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors
Rachele Cagliani, Diego Forni, Mara Biasin, et al.
Journal of Neuroinflammation
|
October 28, 2018
Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
Sunny Malhotra, Luisa M Villar, Carme Costa, et al.
Plos Biology
|
January 5, 2005
Transcription-based prediction of response to IFNbeta using supervised computational methods
Sergio E Baranzini, Parvin Mousavi, Jordi Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 19, 2021
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event
Manuel Comabella, Margareta A Clarke, Sabine Schaedelin, et al.
Nature Reviews. Neurology
|
September 2, 2018
Neurofilaments as biomarkers in neurological disorders
Michael Khalil, Charlotte E Teunissen, Markus Otto, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 17, 2016
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55
Aitzkoa Lopez de Lapuente, Ana Feliú, Nerea Ugidos, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2016
Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55
Aitzkoa Lopez de Lapuente, Ana Feliú, Nerea Ugidos, et al.
Plos One
|
September 3, 2011
Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis
Sunny Malhotra, Marta F Bustamante, Francisco Pérez-Miralles, et al.
European Journal of Neurology
|
August 6, 2025
Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy
Andreu Vilaseca, Helena Ariño, Gloria Iacoboni, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 263) with videos related to
Sort By:
Page
of 27
Frontiers in Immunology
|
August 10, 2023
Molecular signature associated with cladribine treatment in patients with multiple sclerosis
Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
Genome Biology and Evolution
|
April 1, 2014
Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors
Rachele Cagliani, Diego Forni, Mara Biasin, et al.
Journal of Neuroinflammation
|
October 28, 2018
Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
Sunny Malhotra, Luisa M Villar, Carme Costa, et al.
Plos Biology
|
January 5, 2005
Transcription-based prediction of response to IFNbeta using supervised computational methods
Sergio E Baranzini, Parvin Mousavi, Jordi Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 19, 2021
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event
Manuel Comabella, Margareta A Clarke, Sabine Schaedelin, et al.
Nature Reviews. Neurology
|
September 2, 2018
Neurofilaments as biomarkers in neurological disorders
Michael Khalil, Charlotte E Teunissen, Markus Otto, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 17, 2016
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55
Aitzkoa Lopez de Lapuente, Ana Feliú, Nerea Ugidos, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2016
Correction: Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55
Aitzkoa Lopez de Lapuente, Ana Feliú, Nerea Ugidos, et al.
Plos One
|
September 3, 2011
Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis
Sunny Malhotra, Marta F Bustamante, Francisco Pérez-Miralles, et al.
European Journal of Neurology
|
August 6, 2025
Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy
Andreu Vilaseca, Helena Ariño, Gloria Iacoboni, et al.
Page
of 27